Contribution of BCR–ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells
Takeru Nambu, Norie Araki, Aiko Nakagawa, Akihiko Kuniyasu, Tatsuya Kawaguchi, Akinobu Hamada, Hideyuki SaitoVolume:
101
Year:
2010
Language:
english
Pages:
6
DOI:
10.1111/j.1349-7006.2009.01365.x
File:
PDF, 502 KB
english, 2010